1. Field
The present invention generally relates to implants and more particularly to bodily implants and their methods of delivery and placement into a patient's body for the treatment of pelvic floor repair.
2. Description of the Related Art
Genital prolapse or pelvic floor prolapse is the protrusion of pelvic organs into or out of the vaginal canal. Pelvic floor prolapse affects many women and many of them undergo at least one reconstructive pelvic surgery in their lifetime. Many of the cases may be the result of damage to the vaginal and pelvic support tissue by stretching or tearing of the connective tissue within the pelvic space due to childbirth, age, obesity, post-menopausal conditions or chronically elevated intra-abdominal pressure. The results are the distention of organs such as the bladder and rectum, into the vagina, as well as various stages of vaginal avulsion.
Surgical therapy may be performed for the treatment of pelvic organ prolapse. Such surgeries for prolapse treatment may include plication of the torn connective tissues and re-suspension of the vagina. Some traditional suspension techniques include utero-sacral suspension and sacrospinus ligament suspension. Some procedures for vaginal suspension include sacrocolpopexy, where the vagina is suspended to the sacral promontory with an implanted graft material.
Hysterectomy may be performed before conducting sacrocolpopexy. It involves surgical removal of the uterus so that the bodily implant can be attached properly to the anterior and posterior vaginal walls. Hysterectomy may be total (removal of the cervix and the uterus) or partial (removal of the uterus while leaving the cervix intact). This may be an undesirable outcome of pelvic floor repair as removal of the uterus can create many complications and render the patient unable to bear children. Therefore, many women do not prefer removal of the uterus.
Therefore, a medical device and a method for placing the medical device within the patient's body is required that overcomes the need of removal of the uterus through either total or partial hysterectomy.
The present invention discloses a medical device and a method of placing the medical device within a patient's body. The medical device includes a support member, a first elongate member, a second elongate member and a coupling member. The first elongate member and the second elongate member extend from the support member. The first elongate member and the second elongate member include a proximal end portion and a distal end portion. The proximal end portion of the first elongate member is configured to be attached to the support member and the distal end portion of the first elongate member is configured to be attached around a portion of a uterus. The proximal end portion of the second elongate member is configured to be attached to the support member and the distal end portion of the second elongate member is configured to be attached around a portion of a uterus. The coupling member includes a first portion and a second portion. The first portion of the coupling member is coupled to the distal end portion of the first elongate member and the second portion of the coupling member is coupled to the distal end portion of the second elongate member. The first portion of the coupling member and the second portion of the coupling member are further configured to be coupled together.
The invention and the following detailed description of certain embodiments thereof may be understood with reference to the following figures:
Detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure. Further, the terms and phrases used herein are not intended to be limiting, but to provide an understandable description of the invention.
The terms “a” or “an,” as used herein, are defined as one or more than one. The term “another,” as used herein, is defined as at least a second or more. The terms “including” and/or “having”, as used herein, are defined as comprising (i.e., open transition). The term “coupled” or “operatively coupled,” as used herein, is defined as connected, although not necessarily directly and mechanically.
In general, the invention is directed to systems, methods, and devices for treating uterine prolapse. However, the invention may be equally employed for other treatment purposes such as pelvic organ prolapse. As described below in various illustrative embodiments, the invention provides systems, methods, and devices employing an improved medical device configured to be implanted within a patient's body to support pelvic organs for the treatment of pelvic prolapse.
The term patient may be used hereafter for a person who benefits from the medical device or the methods disclosed in the present invention. For example, the patient may be a person whose body receives the medical device disclosed by the present invention in a surgical treatment. For example, in some embodiments, the patient may be a human female, or any other mammal.
The support member 102 is configured to be placed within a patient's body such that the support member 102 disposed adjacent a first bodily portion. In some embodiments, the support member 102 is attached or stitched to the first bodily portion. In some embodiments, the first bodily portion is a portion of an anterior vaginal wall of the patient such that the support member 102 is attached or stitched to the portion of the anterior vaginal wall. In other embodiments, the first bodily portion is a portion of a posterior vaginal wall of the patient such that the support member 102 is configured to support the portion of the posterior vaginal wall.
The support member 102 can be of different shapes, sizes, and configurations depending on the indented use of the medical device 100 and location of its placement within the body of the patient. In some embodiments, the support member 102 can be substantially rectangular, square, oval, or elliptical. The support member 102 can be shaped and sized in conformation to the portions of the vaginal walls of the patient where it is attached or stitched. In accordance with several embodiments, the support member 102 may be configured to conform to the shape of the body of the patient. For example, the support member 102 may be placed in a crescent shape, such as in the shape of a crescent moon, to help it conform to the shape of the anterior wall of the vagina.
The first elongate member 104 extends from the support member 102. The proximal end portion 110 of the first elongate member 104 is attached to the support member 102 and the distal end portion 112 of the first elongate member 104 is configured to be attached around a second bodily portion. In some embodiments, the second bodily portion is a portion of a uterus of the patient such that the distal end portion 112 of the first elongate member 104 is wrapped around the portion of the uterus. In other embodiments, the second bodily portion is a portion of a cervix of the patient such that the distal end portion 112 of the first elongate member 104 is wrapped around the portion of the cervix of the patient. In accordance with some embodiments, the wrapped first elongate member 204 can be stitched around the portion of the uterus or the cervix. Thus the stitched first elongate member 204 provides a support to the uterus and/or the cervix.
The second elongate member 106 extends from the support member 102. The proximal end portion 114 of the second elongate member 106 is attached to the support member 102 and the distal end portion 116 of the second elongate member 106 is configured to be attached around a third bodily portion. In some embodiments, the third bodily portion is a portion of a uterus of the patient such that the distal end portion 116 of the second elongate member 106 is wrapped around the portion of the uterus. In other embodiments, the third bodily portion is a portion of a cervix of the patient such that the distal end portion 116 of the second elongate member 106 is wrapped around the portion of the cervix. In accordance with some embodiments, the wrapped second elongate member 204 can be stitched around the portion of the uterus or the cervix. Thus the stitched second elongate member 204 provides a support to the uterus and/or the cervix. In some embodiments, the second bodily portion and the third bodily portion are same. In some other embodiments, the second bodily portion and the third bodily portion are different.
The first elongate member 104 and second elongate member 106 can be of a variety of different shapes, sizes, and configurations depending on the indented use of the medical device 100 and location of its placement within the body of the patient. In some embodiments, the first elongate member 104 and the second elongate member 106 can be substantially planar, cylindrical, tubular, vasiform, cannular and the like.
In some embodiments, the first elongate member 104 and the second elongate member 106 are integral portions of the support member 102 such that the support member, the first elongate member 104, and the second elongate member form a single integral structure. In other embodiments, the first elongate member 104 and the second elongate member 106 are removably or fixedly coupled to the support member 102 by an operator. The first elongate member 104 and the second elongate member 106 may extend from any location of the support member 102 such that the medical device 100 comfortably supports and retains the prolapsed organ of the patient. In some cases, the first elongated member 104 and the second elongated member 106 can be coupled to the support member 102 at two symmetric locations on either side of a central axis of the support member 102. In other cases, the first elongate member 104 and the second elongate member 106 can be coupled to the support member 102 at two diametrically opposite locations.
In an embodiment, the support member 102, the first elongate member 104, and the second elongate member 106 includes a mesh body that can be made from a biological material or a cadaveric tissue such as stem cells, natural xenograft material, collagen growth factors, and the like. In another embodiment, the support member 102, the first elongate member 104 and the second elongate member 106 includes a mesh body that may be made up of synthetic material such as a plastic, polypropylene mesh or other plastic materials. In some embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are made of a flexible material. In other embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are made of an elastic material. In some embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are formed of the same material. In certain other embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are formed of different materials. For example, the support member 102 can be formed from a first biocompatible material, and the first elongate member 104 and the second elongate member 106 can be formed from a second biocompatible material different than the first biocompatible material.
In some embodiments, the support member 102, the first elongate member 104, and the second elongate member 106 are formed of a material that allows tissue in-growth after implantation. In some embodiments, the elastic and flexible synthetic material employed in the support member 102, the first elongate member 104, and the second elongate member 106 may allow stretching of the medical device 100 without abdominal straining. Additionally, the medical device 100 may be coated, impregnated, or formed with one or more drugs to be eluted to an adjacent tissue, in accordance with several other embodiments.
The support member 102, the first elongate member 104, and the second elongate member 106 can have a variety of sizes (length, width, and thickness) depending on the intended use of a particular medical device such as the medical device 100 and the intended site of implantation. For example, the size of the support member 102 can depend on the size of the vaginal wall. Similarly, the size of the first elongate member 104 and the second elongate member 106 can have a length such that the support member 102 can be placed through and secured to the surrounding bodily tissues properly.
The coupling member 108 includes the first portion 118 and the second portion 120. The first portion 118 of the coupling member 108 is coupled to the distal end portion 112 of the first elongate member 104 and the second portion 120 of the coupling member 108 is coupled to the distal end portion 116 of the second elongate member 106 such that the first portion 118 of the coupling member 108 and the second portion 120 of the coupling member 108 are configured to be coupled together.
The first portion 118 of the coupling member 108 may include a male button. The second portion 120 of the coupling member 108 may include a female button. In some embodiments, the male and female buttons can be made of a polymeric material that may include a natural and/or a synthetic material. Exemplary polymeric materials are polypropylene, polyester, polyethylene, nylon, PVC, polystyrene, and the like. The male and female buttons are preferably made of a non-absorbable plastic material. In other embodiments the buttons may be made of biodegradable plastic material such as Polyglycolide (PGA), Polydioxanone (PDO) and the like.
The medical device 100 may further include a first suture and a second suture (not shown in
In some embodiments, the first suture and the second suture (together hereafter referred to as sutures) may be made of biological materials and/or synthetic materials. The sutures may be either absorbable (naturally biodegradable in the body) or non-absorbable. Exemplary absorbable sutures are polyglycolic acid, polylactic acid, polydioxanone, and the like. Exemplary non-absorbable sutures are nylon, polypropylene and the like. The biologic sutures can be made from biological materials, such as catgut suture, silk and the like. The sutures may be strong enough to hold the medical device securely and may also be flexible enough to be knotted.
In some embodiments, the first suture and the second suture are pulled toward sacrum or a portion of the sacrum with an appropriate tension thereby pulling the support member 102, the first elongate member 104, and the second elongate member 106 upward. This helps in lifting the prolapsed organs such as the anterior vaginal wall, posterior vaginal wall, cervix, and the uterus. An appropriate support is thus provided to the prolapsed organs by the medical device 100.
The support member 202 is configured to be placed within a patient's body such that the support member 202 is attached or stitched to a first bodily portion. In some embodiments, the first bodily portion is a portion of an anterior vaginal wall of the patient such that the support member 202 is attached or stitched to the portion of the anterior vaginal wall. In other embodiments, the first bodily portion is a portion of the posterior vaginal wall of the patient such that the support member 202 is attached or stitched to the portion of the posterior vaginal wall.
The support member 202 can be of a variety of different shapes, sizes, and configurations depending on the indented use of the medical device 200 and location of its placement within the body of the patient. In some embodiments, the support member 202 can be substantially rectangular, square, oval, or elliptical. The support member 202 can be shaped and sized in conformation to the portions of the vaginal walls of the patient where it is attached or stitched. In accordance with several embodiments, the support member 202 may be configured to conform to the shape of the body of the patient. For example, the support member 202 may be placed in a crescent shape, such as in the shape of a crescent moon, to help it conform to the anterior wall of the vagina.
The first elongate member 204 extends from the support member 202. The first elongate member 204 includes a proximal end portion 210 and a distal end portion 212 such that the proximal end portion 210 is attached to the support member 202 and the distal end portion 212 of the first elongate member 204 is configured to be attached around a second bodily portion. In some embodiments, the second bodily portion is a portion of a uterus of the patient such that the distal end portion 212 of the first elongate member 204 is wrapped around the portion of the uterus. In other embodiments, the second bodily portion is a portion of a cervix of the patient such that the distal end portion 212 of the first elongate member 204 is wrapped around the portion of the cervix.
The second elongate member 206 extends from the support member 202. The second elongate member 206 includes a proximal end portion 214 and a distal end portion 216 such that the proximal end portion 214 is attached to the support member 202 and the distal end portion 216 of the second elongate member 206 is configured to be attached around a third bodily portion. In some embodiments, the third bodily portion is a portion of a uterus of the patient such that the distal end portion 216 of the second elongate member 206 is wrapped around the portion of the uterus. In other embodiments, the third bodily portion is a portion of the cervix of the patient such that the distal end portion 216 of the second elongate member 206 is wrapped around the portion of the uterus. In some embodiments, the second bodily portion and the third bodily portion are same. In some other embodiments, the second bodily portion and the third bodily portion are different.
The first elongate member 204 and the second elongate member 206 can be of a variety of different shapes, sizes, and configurations depending on the indented use of the medical device 100 and location of its placement within the body of the patient. In some embodiments, the first elongate member 204 and the second elongate member 206 can be substantially planar, cylindrical, tubular, vasiform, cannular and the like. The first elongate member 204 and the second elongate member 206 can be shaped and sized to support the portion of the vaginal wall of the patient. In accordance with several embodiments, the first elongate member 204 and the second elongate member 206 may be configured to conform to the shape of the body of the patient. For example, the first and the second elongate members 204 and 206 may be placed in a cylindrical shape, such as in the shape of a hollow cylinder, to help it conform to and wrap around the cervix or the uterus of the patient.
In some embodiments, the first elongate member 204 and the second elongate member 206 are integral portions of the support member 202 such that the support member 202, the first elongate member 204 and the second elongate member 206 form a single integral structure. In other embodiments, the first elongate member 204 and the second elongate member 206 are removably or fixedly coupled to the support member 202. The first elongate member 204 and the second elongate member 206 may extend from any location of the support member 202 such that the medical device 200 comfortably supports and retains body portions of the patient. In some cases, the first elongated member 204 and the second elongated member 206 can be coupled to the support member 202 at two symmetric locations on either side of a central axis of the support member 202. In other cases, the first elongate member 204 and the second elongate member 206 can be coupled to the support member 202 at diametrically opposite locations.
In some embodiments, the support member 202, the first elongate member 204, and the second elongate member 206 are formed of a material that allows tissue in-growth after implantation. Various types of materials that can be employed to manufacture the support member 202, the first elongate member 204, and the second elongate member 206 have been described in conjunction with
The support member 202, the first elongate member 204, and the second elongate member 206 can have a variety of sizes (length, width, and thickness) depending on the intended use of a particular medical device such as the medical device 200 and the intended site of implantation. For example, the size of the support member 202 can depend on the size of the vaginal wall. Similarly, the size of the first elongate member 204 and second elongate member 206 can have a length such that the support member 202 can be placed through and secured to the surrounding bodily tissues properly.
The coupling member 208 includes a first portion 218 and a second portion 220. The first portion 218 of the coupling member 208 is coupled to the distal end portion 212 of the first elongate member 204 and the second portion 220 of the coupling member 208 is coupled to the distal end portion 216 of the second elongate member 206, wherein the first portion 218 of the coupling member 208 and the second portion 220 of the coupling member 208 are configured to be coupled together. The first portion 218 of the coupling member 208 includes a male button 222. The second portion 220 of the coupling member 208 includes a female button 224. The male button 222 of the coupling member 208 is configured to be plugged in to the female button 224 of the coupling member 208 thereby coupling the first elongate member 204 and the second elongate member 206 together. The male and female buttons 222 and 224 of the coupling member 208 are further described in conjunction with
The medical device 200 also includes a first suture 226 and a second suture 228. The first suture 226 includes a proximal end portion 230 and a distal end portion 232 and the second suture 228 also includes a proximal end portion 234 and a distal end portion 236. The proximal end portion 230 of the first suture 226 is coupled to the first portion 218 of the coupling member 208 and the distal end portion 232 of the first suture 226 is configured to be attached to a fourth bodily portion. The proximal end portion 234 of the second suture 228 is coupled to the second portion 220 of the coupling member 208 and the distal end portion 236 of the second suture 228 is configured to be attached to a fifth bodily portion. In some embodiments, the fourth bodily portion and the fifth bodily portion is a sacrum of the patient. In some other embodiments, the fourth bodily portion and the fifth bodily portion can be any other location close to the sacrum. In some embodiments, the second bodily portion and the third bodily portion are same. In some other embodiments, the second bodily portion and the third bodily portion are different. The first suture 226 and the second suture 228 have also been discussed in conjunction with
The female button 310 includes a head portion 316 such that the head portion 316 is a disc or harrow shaped structure, and the like. The head portion 316 of the female button 310 is hollow formed by inner peripheral surfaces of the female button 310. The cylindrical leg portion 314 of the male button 308 is capable of passing through the hollow portion formed by the inner peripheral surfaces of the female button 310. The male button 308 of the coupling member 302 and the female button 310 of the coupling member 302 are configured to be removably coupled together as illustrated in
The coupling member 202, first portion 204, and the second portion 206 as described above for coupling purposes is merely exemplary and it must be appreciated that various other types of coupling members as used in the conventional art can also be employed for the purposes of the present invention.
As illustrated, the support member 202 is attached or stitched to a portion of the anterior vaginal wall 404 of the patient. In other embodiments, the support member 202 may be attached or stitched to a portion of the posterior vaginal wall 406. In accordance with the illustrated embodiment, the support member 202 can be shaped and sized in conformation to the portion of the anterior vaginal wall 404 of the patient where it is attached or stitched. For example, the support member 202 may be placed in a crescent shape, such as in the shape of a crescent moon, to help it conform to the anterior vaginal wall 404. The first elongate member 204 extends from the support member 202. The proximal end portion 210 of the first elongate member 204 is attached to the support member 202 and the distal end portion 212 of the first elongate member 204 is attached around a portion of the uterus 412. The second elongate member 206 also extends from the support member 202. The proximal end portion 214 of the second elongate member 206 is attached to the support member 202 and the distal end portion 216 of the second elongate member 206 is attached around a portion of the uterus 412. Further, the proximal end portion 230 of the first suture 226 is coupled to the first portion 218 of the coupling member 208 and the distal end portion 232 of the first suture 226 is attached to the sacrum or close to the sacrum 408. The proximal end portion 234 of the second suture 228 is coupled to the second portion 220 of the coupling member 208 and the distal end portion 236 of the second suture 228 is attached to the sacrum or close to the sacrum 408.
Referring now to
The method 500 includes delivering the medical device 200 inside the patient's body at step 502. The medical device 200 includes the support member 202, the first elongate member 204, and the second elongate member 206 extending from the support member 202. The medical device 200 further includes the coupling member 208 having the first portion 218 and the second portion 220. The medical device 200 has been described above in conjunction with
The method further includes coupling the first portion 218 of the coupling member 208 with the second portion 220 of the coupling member 208 at step 504. Coupling of the first portion 218 and the second portion 220 can be done through male and female buttons 222 and 224 as illustrated in
After the medical device 200 is delivered and the first portion 218 is coupled with the second portion 220, the operator may wrap the first elongate member 204 and the second elongate member 206 around the cervix 410 or the uterus 412 or a portion of the cervix 410 or the uterus 412 of the patient. Thus, the wrapped elongate members 204 and 206 together with the support member 202 provide a desired support to the anterior and/or posterior vaginal walls 404 and 406 and the cervix or the uterus 410 and 412 of the patient. Similarly, any other prolapsed organ can be supported and lifted with the use of the medical device 200.
The method further includes fixing the first suture 226 and the second suture 228 to the sacrum 408 of the patient. As discussed in conjunction with
In some embodiments, the sutures 226 and 228 are pulled toward sacrum 208 with an appropriate tension thereby pulling the support member 202, the first elongate member 204, and the second elongate member 206 upward. This helps in lifting the prolapsed organs such as the anterior vaginal wall 404, posterior vaginal wall 406, cervix 410, and the uterus 412. An appropriate support is thus provided to the prolapsed organs by the medical device 200.
It must be appreciated that the coupling of the first and second portion 218 and 220 of the coupling member 208 holds the first elongate member 204 and the second elongate member 206 together at the uterus or the cervix 412/410 but may not appropriately tension them. In some embodiments, it is through the first suture 226 and the second suture 228 that the tension capable of treating pelvic disorders is provided. In some embodiments, since the sutures 226 and 228 are very thin as compared to the width of the elongate members 204 and 206, therefore they can be passed through anatomical locations from the vaginal walls 404 and 406 to the sacrum 408 easily. Therefore, removal of the uterus 412 is avoided through the disclosed surgical procedure.
In some embodiments, a medical device configured to be delivered and placed within a patient's body includes a support member, a first elongate member, a second elongate member and a coupling member. The support member is configured to be attached to a portion of a vaginal wall. The first elongate member extends from the support member, the first elongate member having a proximal end portion and a distal end portion such that the proximal end portion is attached to the support member and the distal end portion of the first elongate member being configured to be attached around a portion of a uterus. The second elongate member extending from the support member, the second elongate member having a proximal end portion and a distal end portion such that the proximal end portion is attached to the support member and the distal end portion of the second elongate member being configured to be attached around a portion of the uterus. The coupling member having a first portion and a second portion, the first portion of the coupling member coupled to the distal end portion of the first elongate member and the second portion of the coupling member coupled to the distal end portion of the second elongate member, wherein the first portion of the coupling member and the second portion of the coupling member are configured to be coupled together.
In some embodiments, the medical device is a bodily implant configured to treat uterine prolapse. In some embodiments, the support member includes a mesh configured to be stitched to the portion of the vaginal wall. In some embodiments, the vaginal wall is an anterior vaginal wall of the patient such that the support member is configured to be stitched to the anterior vaginal wall. In some embodiments, the coupling member is made of a plastic. In some embodiments, the plastic is polypropylene. In some embodiments, the coupling member is made of a biodegradable material. In some embodiments, the first portion of the coupling member includes a male button. In some embodiments, the second portion of the coupling member includes a female button. In some embodiments, the coupling member is made of a non-absorbable plastic. In some embodiments, the coupling member is made of a biodegradable material.
In some embodiments, the device includes a first suture having a proximal end portion and a distal end portion, wherein the proximal end portion of the first suture is coupled to the first portion of the coupling member and the distal end portion of the first suture is configured to be attached to a portion of a sacrum of the patient.
In some embodiments, the device includes a second suture having a proximal end portion and a distal end portion, wherein the proximal end portion of the second suture is coupled to the second portion of the coupling member and the distal end portion of the second suture is configured to be attached to a portion of the sacrum of the patient.
In some embodiments, a method of placing a medical device in a patient's body, includes delivering the medical device inside the patient's body, the medical device having a support member configured to be attached to a portion of a vaginal wall, a first elongate member and a second elongate member extending from the support member and configured to be attached around a portion of a uterus, a coupling member having a first portion and a second portion, the first portion of the coupling member coupled to the first elongate member and the second portion of the coupling member coupled to the second elongate member; coupling the first portion of the coupling member with the second portion of the coupling member; and fixing a first suture and a second suture to a sacrum of the patient, the first suture attached to the first portion of the coupling member through its proximal end and the second suture attached to the second portion of the coupling member through its proximal end.
In some embodiments, the method includes creating an access to a vagina for delivery of the medical device. In some embodiments, the access is created transvaginally.
In some embodiments, the method includes stitching the support member to the portion of the vaginal wall. In some embodiments, the vaginal wall is an anterior vaginal wall.
In some embodiments, the method includes pulling the medical device to a defined anatomical location with the use of the first suture and the second suture. In some embodiments, the medical device is a bodily implant configured to treat uterine prolapse.
While the invention has been disclosed in connection with the preferred embodiments shown and described in detail, various modifications and improvements thereon will become readily apparent to those skilled in the art. Accordingly, the spirit and scope of the present invention is not to be limited by the foregoing examples, but it is to be understood in the broadest sense allowable by law.
This application is a Nonprovisional of, and claims priority to, U.S. Patent Application No. 61/532,809, filed Sep. 9, 2011, entitled “A MEDICAL DEVICE AND METHODS OF DELIVERING THE MEDICAL DEVICE”, which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
669034 | Manly | Feb 1901 | A |
2687131 | Raiche | Aug 1954 | A |
3123077 | Alcamo | Mar 1964 | A |
4083369 | Sinnreich | Apr 1978 | A |
4324331 | Ignasiak | Apr 1982 | A |
4792336 | Hlavacek et al. | Dec 1988 | A |
4919667 | Richmond | Apr 1990 | A |
4998912 | Scarbrough et al. | Mar 1991 | A |
5013292 | Lemay | May 1991 | A |
5082112 | Dunklee | Jan 1992 | A |
5112344 | Petros | May 1992 | A |
5149329 | Richardson | Sep 1992 | A |
5217466 | Hasson | Jun 1993 | A |
5217486 | Rice et al. | Jun 1993 | A |
5217494 | Coggins et al. | Jun 1993 | A |
5263969 | Phillips | Nov 1993 | A |
5356432 | Rutkow et al. | Oct 1994 | A |
5362294 | Seitzinger | Nov 1994 | A |
5364408 | Gordon | Nov 1994 | A |
5383905 | Golds et al. | Jan 1995 | A |
5405359 | Pierce | Apr 1995 | A |
5425747 | Brotz | Jun 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5458609 | Gordon et al. | Oct 1995 | A |
5458636 | Brancato | Oct 1995 | A |
5464409 | Mohajer | Nov 1995 | A |
5485917 | Early | Jan 1996 | A |
5527341 | Gogolewski et al. | Jun 1996 | A |
5534008 | Acksel | Jul 1996 | A |
5540704 | Gordon et al. | Jul 1996 | A |
5562689 | Green et al. | Oct 1996 | A |
5569283 | Green et al. | Oct 1996 | A |
5575800 | Gordon | Nov 1996 | A |
5578044 | Gordon et al. | Nov 1996 | A |
5584859 | Brotz | Dec 1996 | A |
5611515 | Benderev et al. | Mar 1997 | A |
5643311 | Smith et al. | Jul 1997 | A |
5662664 | Gordon | Sep 1997 | A |
5683402 | Cosgrove et al. | Nov 1997 | A |
5700272 | Gordon et al. | Dec 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5713910 | Gordon et al. | Feb 1998 | A |
5720761 | Kaali | Feb 1998 | A |
5741277 | Gordon et al. | Apr 1998 | A |
5741279 | Gordon et al. | Apr 1998 | A |
5741299 | Rudt | Apr 1998 | A |
5840011 | Landgrebe et al. | Nov 1998 | A |
5871488 | Tovey et al. | Feb 1999 | A |
5899909 | Claren et al. | May 1999 | A |
5922826 | Kuze et al. | Jul 1999 | A |
5931855 | Buncke | Aug 1999 | A |
5948001 | Larsen | Sep 1999 | A |
5976127 | Lax | Nov 1999 | A |
5988549 | Hitomi et al. | Nov 1999 | A |
6010447 | Kardjian | Jan 2000 | A |
6012580 | Peters et al. | Jan 2000 | A |
6039686 | Kovac | Mar 2000 | A |
6042534 | Gellman et al. | Mar 2000 | A |
6042536 | Tihon et al. | Mar 2000 | A |
6042592 | Schmitt | Mar 2000 | A |
6044847 | Carter et al. | Apr 2000 | A |
6048351 | Gordon et al. | Apr 2000 | A |
6096051 | Kortenbach et al. | Aug 2000 | A |
6102921 | Zhu et al. | Aug 2000 | A |
6195646 | Grosh et al. | Feb 2001 | B1 |
6197036 | Tripp et al. | Mar 2001 | B1 |
6200330 | Benderev et al. | Mar 2001 | B1 |
6221005 | Bruckner et al. | Apr 2001 | B1 |
6224616 | Kugel | May 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6273852 | Lehe et al. | Aug 2001 | B1 |
6306079 | Trabucco | Oct 2001 | B1 |
6322492 | Kovac | Nov 2001 | B1 |
6328686 | Kovac | Dec 2001 | B1 |
6346111 | Gordon et al. | Feb 2002 | B1 |
6375662 | Schmitt | Apr 2002 | B1 |
6382214 | Raz et al. | May 2002 | B1 |
6406423 | Scetbon | Jun 2002 | B1 |
6454778 | Kortenbach | Sep 2002 | B2 |
6478727 | Scetbon | Nov 2002 | B2 |
6491703 | Ulmsten | Dec 2002 | B1 |
6502578 | Raz et al. | Jan 2003 | B2 |
6506190 | Walshe | Jan 2003 | B1 |
6530943 | Hoepffner et al. | Mar 2003 | B1 |
6544273 | Harari et al. | Apr 2003 | B1 |
6547800 | Foerster et al. | Apr 2003 | B2 |
6551329 | Kortenbach et al. | Apr 2003 | B1 |
6565580 | Beretta | May 2003 | B1 |
6575998 | Beyar | Jun 2003 | B2 |
6582443 | Cabak et al. | Jun 2003 | B2 |
6592515 | Thierfelder et al. | Jul 2003 | B2 |
6592610 | Beyar et al. | Jul 2003 | B2 |
6595911 | LoVuolo | Jul 2003 | B2 |
6596001 | Stormby et al. | Jul 2003 | B2 |
6599235 | Kovac | Jul 2003 | B2 |
6599310 | Leung et al. | Jul 2003 | B2 |
6612977 | Staskin et al. | Sep 2003 | B2 |
6638209 | Landgrebe | Oct 2003 | B2 |
6638210 | Berger | Oct 2003 | B2 |
6638211 | Suslian et al. | Oct 2003 | B2 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6641524 | Kovac et al. | Nov 2003 | B2 |
6641525 | Rocheleau et al. | Nov 2003 | B2 |
6648899 | Kalinski et al. | Nov 2003 | B2 |
6648921 | Anderson et al. | Nov 2003 | B2 |
6652450 | Neisz et al. | Nov 2003 | B2 |
6666817 | Li | Dec 2003 | B2 |
6669706 | Schmitt et al. | Dec 2003 | B2 |
6669735 | Pelissier | Dec 2003 | B1 |
6673010 | Skiba et al. | Jan 2004 | B2 |
6691711 | Raz et al. | Feb 2004 | B2 |
6695855 | Gaston | Feb 2004 | B1 |
6702827 | Lund et al. | Mar 2004 | B1 |
6730110 | Harari et al. | May 2004 | B1 |
6746455 | Beyar et al. | Jun 2004 | B2 |
6752814 | Gellman et al. | Jun 2004 | B2 |
6755781 | Gellman | Jun 2004 | B2 |
6808487 | Migliari | Oct 2004 | B2 |
6830052 | Carter et al. | Dec 2004 | B2 |
6848152 | Genova | Feb 2005 | B2 |
6881184 | Zappala | Apr 2005 | B2 |
6890338 | Davis et al. | May 2005 | B1 |
6908425 | Luscombe | Jun 2005 | B2 |
6911003 | Anderson et al. | Jun 2005 | B2 |
6911034 | Nobles et al. | Jun 2005 | B2 |
6932759 | Kammerer et al. | Aug 2005 | B2 |
6936052 | Gellman et al. | Aug 2005 | B2 |
6936054 | Chu | Aug 2005 | B2 |
6936952 | Takamine | Aug 2005 | B2 |
6946003 | Wolowacz et al. | Sep 2005 | B1 |
6953428 | Gellman et al. | Oct 2005 | B2 |
6960160 | Browning | Nov 2005 | B2 |
6971986 | Staskin et al. | Dec 2005 | B2 |
6986780 | Rudnick et al. | Jan 2006 | B2 |
6991597 | Gellman et al. | Jan 2006 | B2 |
7011688 | Gryska et al. | Mar 2006 | B2 |
7025772 | Gellman et al. | Apr 2006 | B2 |
7048682 | Neisz et al. | May 2006 | B2 |
7056333 | Walshe | Jun 2006 | B2 |
7070556 | Anderson et al. | Jul 2006 | B2 |
7070558 | Gellman et al. | Jul 2006 | B2 |
7083568 | Neisz et al. | Aug 2006 | B2 |
7083637 | Tannhauser | Aug 2006 | B1 |
7090686 | Nobles et al. | Aug 2006 | B2 |
7094199 | Petros et al. | Aug 2006 | B2 |
7112171 | Rocheleau et al. | Sep 2006 | B2 |
7112210 | Ulmsten et al. | Sep 2006 | B2 |
7122039 | Chu | Oct 2006 | B2 |
7131943 | Kammerer | Nov 2006 | B2 |
7131944 | Jacquetin | Nov 2006 | B2 |
7198597 | Siegel et al. | Apr 2007 | B2 |
7204801 | Grocela | Apr 2007 | B2 |
7204802 | De Leval | Apr 2007 | B2 |
7223229 | Inman et al. | May 2007 | B2 |
7226407 | Kammerer et al. | Jun 2007 | B2 |
7226408 | Harai et al. | Jun 2007 | B2 |
7229453 | Anderson et al. | Jun 2007 | B2 |
7235043 | Gellman et al. | Jun 2007 | B2 |
7244260 | Koseki | Jul 2007 | B2 |
7244759 | Muller et al. | Jul 2007 | B2 |
7267645 | Anderson et al. | Sep 2007 | B2 |
7291104 | Neisz et al. | Nov 2007 | B2 |
7351197 | Montpetit et al. | Apr 2008 | B2 |
7361138 | Wagner et al. | Apr 2008 | B2 |
7364541 | Chu et al. | Apr 2008 | B2 |
7402133 | Chu et al. | Jul 2008 | B2 |
7413540 | Gellman et al. | Aug 2008 | B2 |
7527588 | Zaddem | May 2009 | B2 |
7878970 | Goldberg | Feb 2011 | B2 |
20010023356 | Raz et al. | Sep 2001 | A1 |
20010049467 | Lehe et al. | Dec 2001 | A1 |
20020010457 | Duchon et al. | Jan 2002 | A1 |
20020028980 | Thierfelder et al. | Mar 2002 | A1 |
20020099259 | Anderson et al. | Jul 2002 | A1 |
20020128670 | Ulmsten et al. | Sep 2002 | A1 |
20020133236 | Rousseau | Sep 2002 | A1 |
20020143234 | LoVuolo | Oct 2002 | A1 |
20020147382 | Neisz et al. | Oct 2002 | A1 |
20020151909 | Gellman et al. | Oct 2002 | A1 |
20020156489 | Gellman et al. | Oct 2002 | A1 |
20030009181 | Gellman et al. | Jan 2003 | A1 |
20030023138 | Luscombe | Jan 2003 | A1 |
20030023250 | Watschke et al. | Jan 2003 | A1 |
20030055313 | Anderson et al. | Mar 2003 | A1 |
20030078604 | Walshe | Apr 2003 | A1 |
20030125715 | Kuehn et al. | Jul 2003 | A1 |
20030149334 | Ulmsten et al. | Aug 2003 | A1 |
20030176762 | Kammerer | Sep 2003 | A1 |
20030191360 | Browning | Oct 2003 | A1 |
20030208208 | Chu | Nov 2003 | A1 |
20030220538 | Jacquetin | Nov 2003 | A1 |
20030225424 | Benderev | Dec 2003 | A1 |
20030233107 | Gellman et al. | Dec 2003 | A1 |
20030233108 | Gellman et al. | Dec 2003 | A1 |
20040006353 | Bosley et al. | Jan 2004 | A1 |
20040015048 | Neisz et al. | Jan 2004 | A1 |
20040015177 | Chu | Jan 2004 | A1 |
20040034372 | Chu | Feb 2004 | A1 |
20040039246 | Gellman et al. | Feb 2004 | A1 |
20040039453 | Anderson et al. | Feb 2004 | A1 |
20040059293 | Chu et al. | Mar 2004 | A1 |
20040068159 | Neisz et al. | Apr 2004 | A1 |
20040073234 | Chu et al. | Apr 2004 | A1 |
20040087970 | Chu et al. | May 2004 | A1 |
20040106847 | Benderev | Jun 2004 | A1 |
20040116944 | Chu et al. | Jun 2004 | A1 |
20040133217 | Watschke | Jul 2004 | A1 |
20040138747 | Kaladelfos | Jul 2004 | A1 |
20040181243 | Chu et al. | Sep 2004 | A1 |
20040186515 | Rosenblatt | Sep 2004 | A1 |
20040225181 | Chu et al. | Nov 2004 | A1 |
20040230206 | Gellman et al. | Nov 2004 | A1 |
20040231678 | Fierro | Nov 2004 | A1 |
20040236356 | Rioux et al. | Nov 2004 | A1 |
20040249397 | Delorme et al. | Dec 2004 | A1 |
20040249473 | Delorme et al. | Dec 2004 | A1 |
20050004427 | Cervigni | Jan 2005 | A1 |
20050004576 | Benderev | Jan 2005 | A1 |
20050038451 | Rao et al. | Feb 2005 | A1 |
20050038452 | Chu | Feb 2005 | A1 |
20050075660 | Chu et al. | Apr 2005 | A1 |
20050080317 | Merade | Apr 2005 | A1 |
20050090706 | Gellman | Apr 2005 | A1 |
20050096499 | Li et al. | May 2005 | A1 |
20050101834 | Merade | May 2005 | A1 |
20050107805 | Bouffier et al. | May 2005 | A1 |
20050131391 | Chu et al. | Jun 2005 | A1 |
20050131392 | Chu et al. | Jun 2005 | A1 |
20050131393 | Chu et al. | Jun 2005 | A1 |
20050177022 | Chu et al. | Aug 2005 | A1 |
20050192600 | Nicolo et al. | Sep 2005 | A1 |
20050222589 | Chu | Oct 2005 | A1 |
20050222591 | Gingras et al. | Oct 2005 | A1 |
20050234291 | Gingras | Oct 2005 | A1 |
20050245787 | Cox et al. | Nov 2005 | A1 |
20050250977 | Montpetit et al. | Nov 2005 | A1 |
20050250978 | Kammerer | Nov 2005 | A1 |
20050256366 | Chu | Nov 2005 | A1 |
20050256530 | Petros | Nov 2005 | A1 |
20050261545 | Gellman et al. | Nov 2005 | A1 |
20050261547 | Bouffier | Nov 2005 | A1 |
20050277807 | MacLean et al. | Dec 2005 | A1 |
20050278037 | Delorme et al. | Dec 2005 | A1 |
20060015001 | Staskin et al. | Jan 2006 | A1 |
20060025649 | Smith et al. | Feb 2006 | A1 |
20060025783 | Smith et al. | Feb 2006 | A1 |
20060041185 | Browning | Feb 2006 | A1 |
20060041263 | Chu et al. | Feb 2006 | A1 |
20060052801 | Dreyfuss et al. | Mar 2006 | A1 |
20060058574 | Priewe et al. | Mar 2006 | A1 |
20060058575 | Zaddem et al. | Mar 2006 | A1 |
20060069301 | Neisz et al. | Mar 2006 | A1 |
20060089524 | Chu | Apr 2006 | A1 |
20060089525 | Mamo et al. | Apr 2006 | A1 |
20060122457 | Kovac et al. | Jun 2006 | A1 |
20060173237 | Jacquetin | Aug 2006 | A1 |
20060205995 | Browning | Sep 2006 | A1 |
20060211911 | Jao et al. | Sep 2006 | A1 |
20060229596 | Weiser et al. | Oct 2006 | A1 |
20060264698 | Kondonis et al. | Nov 2006 | A1 |
20070161849 | Goldberg et al. | Jul 2007 | A1 |
20070173864 | Chu | Jul 2007 | A1 |
20070270890 | Miller | Nov 2007 | A1 |
20070276358 | Barzell et al. | Nov 2007 | A1 |
20080234543 | Goldwasser | Sep 2008 | A1 |
20090171140 | Chu | Jul 2009 | A1 |
20100130814 | Dubernard | May 2010 | A1 |
20100152530 | Timmer et al. | Jun 2010 | A1 |
20110098527 | Goldberg | Apr 2011 | A1 |
20110112357 | Chapman et al. | May 2011 | A1 |
20120059217 | Goldberg | Mar 2012 | A1 |
20120136324 | Hanuka et al. | May 2012 | A1 |
Number | Date | Country |
---|---|---|
10056169 | Jun 2002 | DE |
0088714 | Sep 1983 | EP |
0141589 | May 1985 | EP |
0299158 | Jan 1989 | EP |
0362146 | Apr 1990 | EP |
0412664 | Feb 1991 | EP |
0567130 | Oct 1993 | EP |
0774240 | May 1997 | EP |
1201189 | May 2002 | EP |
1508305 | Feb 2005 | EP |
1520554 | Apr 2005 | EP |
1609439 | Dec 2005 | EP |
2785521 | May 2000 | FR |
2852817 | Oct 2004 | FR |
2852818 | Oct 2004 | FR |
2871365 | Dec 2005 | FR |
670349 | Apr 1952 | GB |
06114067 | Apr 1994 | JP |
08117239 | May 1996 | JP |
PA04008407 | Dec 2005 | MX |
9609796 | Apr 1996 | WO |
9639948 | Dec 1996 | WO |
9835616 | Aug 1998 | WO |
9835632 | Aug 1998 | WO |
9843545 | Oct 1998 | WO |
9937216 | Jul 1999 | WO |
0009039 | Feb 2000 | WO |
0074613 | Dec 2000 | WO |
0106951 | Feb 2001 | WO |
0152135 | Jul 2001 | WO |
0231681 | Apr 2002 | WO |
0232284 | Apr 2002 | WO |
0238079 | May 2002 | WO |
02058563 | Aug 2002 | WO |
02062237 | Aug 2002 | WO |
02078571 | Oct 2002 | WO |
03068107 | Aug 2003 | WO |
03073960 | Sep 2003 | WO |
03092546 | Nov 2003 | WO |
03096928 | Nov 2003 | WO |
03096929 | Nov 2003 | WO |
2004012626 | Feb 2004 | WO |
2004016196 | Feb 2004 | WO |
2004045457 | Oct 2004 | WO |
2004091442 | Oct 2004 | WO |
2004091443 | Oct 2004 | WO |
2005051204 | Jun 2005 | WO |
2005122721 | Dec 2005 | WO |
2005122954 | Dec 2005 | WO |
2006046950 | May 2006 | WO |
2007014240 | Feb 2007 | WO |
2007016698 | Feb 2007 | WO |
2007019374 | Feb 2007 | WO |
2007038589 | Apr 2007 | WO |
2007087132 | Aug 2007 | WO |
2009038781 | Mar 2009 | WO |
2009102945 | Aug 2009 | WO |
2012030834 | Mar 2012 | WO |
2012030834 | Mar 2012 | WO |
Entry |
---|
Leron, E. et al., “Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse”, British Journal of Obstetrics and Gynaecology, 108.3, 2001, pp. 629-633. |
“Capio® CL Transvaginal Suture Capturing Device”, Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, 2000, 4 pages. |
“Capio® Open Access and Standard Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, printed on Apr. 7, 2006, 2 pages. |
“Capio® RP Suture Device”, Boston Scientific, printed on Apr. 7, 2006, 1 page. |
Hardiman, et al, “Sacrospinous Vault Suspension and Abdonimal Colposacropexy: Success Rates and Complications”, Section of Urogynecology, Department of Obstetrics and Gynecology, University of Toronto, Mount Sinai Hospital, Sep. 18, 1995, 5 pages. |
Pohl, et al, “Bilateral Transvaginal Sacrospinous Colpopexy: Preliminary Experience”, 23rd Annual Meeting of the Society of Gynecologic Surgeons, Feb. 24-26, 1997, 7 pages. |
Shah, et al, “Short-Term Outcome Analysis of Total Pelvic Reconstruction With Mesh: The Vaginal Approach”, The Journal of Urology, vol. 171, Jan. 2004, pp. 261-263. |
Number | Date | Country | |
---|---|---|---|
20130066145 A1 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
61532809 | Sep 2011 | US |